Advert - AbbVie – Case AUTH/3712/11/22
-
Date posted18 October 2023
-
SanctionAdvertisement,
-
Case number/s
For the use of the imagery of a young female surfing that did not reflect the typical patient with moderate to severe psoriatic arthritis and could not be substantiated and for the use of imagery of a young female in relation to Rinvoq (upadacitinib), a product with a known risk of foetal harm without highlighting that there were restrictions on use in this population which had the potential to impact patient safety, AbbVie was ruled in breach of the following clauses of the 2021 Code:
Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 5.1 - Failing to maintain high standards
Clause 6.1 - Failing to ensure material was sufficiently complete and not misleading
Clause 6.2 - Making an unsubstantiated claim
Clause 6.3 - Failing to ensure artwork conformed to the letter and spirit of the Code